Sino Biological (SZSE:301047) Other Net Income (Loss) : ¥0.0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Sino Biological Other Net Income (Loss)?

Sino Biological's Other Net Income (Loss) for the three months ended in Dec. 2023 was ¥0.0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2023 was ¥0.0 Mil.

Sino Biological's quarterly Other Net Income (Loss) declined from Jun. 2023 (¥0.0 Mil) to Sep. 2023 (¥-0.0 Mil) but then increased from Sep. 2023 (¥-0.0 Mil) to Dec. 2023 (¥0.0 Mil).

Sino Biological's annual Other Net Income (Loss) increased from Dec. 2021 (¥0.0 Mil) to Dec. 2022 (¥0.0 Mil) but then declined from Dec. 2022 (¥0.0 Mil) to Dec. 2023 (¥0.0 Mil).

Sino Biological Other Net Income (Loss) Historical Data

The historical data trend for Sino Biological's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sino Biological Other Net Income (Loss) Chart

Sino Biological Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Net Income (Loss)

Get a 7-Day Free Trial

Sino Biological Quarterly Data
	Dec17	Dec18	Jun19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

Sino Biological Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.0 Mil.

Sino Biological Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Sino Biological's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Sino Biological (SZSE:301047) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sino Biological Inc (SZSE:301047) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 18 Kechuang 10th Street, Room 306, Building 9, Beijing Economic and Technological Development Zon, Beijing, CHN, 100176

Website

https://www.sinobiological.com

Sino Biological Inc is an international reagent supplier and service provider. The company specializes in recombinant protein production and antibody development. All of Sino Biological's products are independently developed and produced, including recombinant proteins, antibodies and cDNA clones.

Sino Biological (SZSE:301047) Headlines

No Headlines